From Verify.Wiki
Jump to: navigation, search

Accelovance is an award winning, clinical development Contract Research Organization (CRO) focused on oncology, vaccine, and general medicine Phase I-IV programs. Providing a full complement of global CRO services to pharmaceutical companies, biotechs; Accelovance supports client needs by leveraging operational knowledge and successful results including study execution, resourcing, pharmacovigilance/safety, site identification, and patient recruitment strategies. [1]

QuickUpload1048 20170811130634.png
Accelovance, Inc
Type Private
Industry Biotechnology
Founded 2005
Headquarters Rockville, MD
Key people Stephen J. Trevisan, President and CEO
Number of employees 201-500 employees


Contract Research Organization

  • Protocol Development
  • Project Management
  • Clinical Trial Monitoring
  • Data Management
  • Biostatistics
  • Pharmacovigilance
  • Regulatory Affairs
  • Medical Writing

Clinical Call Center

  • Recruitment/retention/compliance
  • Clinical Call CenterPost approval safety studies
  • Phase IV studies
  • Surveillance programs
  • Patient-reported outcomes
  • Observational studies
  • Registries
  • Site support services
  • Patient market research
  • Risk management support
  • Geriatric and targeted populations
  • Coverage across global timezones

Accelovance Elite Monitoring


Patient safety is critical to every study. Accelovance offers a comprehensive suite of pharmacovigilance and safety monitoring services in a variety of therapeutic areas.

  • Medical Monitoring
  • Coding of adverse events and medications (MedDRA and WHO Drug)
  • Review and management of suspected serious adverse reactions
  • Preparation of MedWatch and CIOMS forms
  • Preparation of safety narratives
  • Individual Case Safety Report (ICSR) processing for serious adverse events
  • Management of adjudication and data safety monitoring committees

Accelovance's Pharmacovigilance Services : Adverse Event (AE) Management Intake Triage Case processing in ARISg, a validated safety database Narrative writing Medical and product coding using MedDRA and WHODrug Dictionary Vigorous internal QC process Medical Review Unlimited follow up (as required) for additional information Reconciliation with Medical Information call center Literature Review Weekly or monthly literature review Identification, assessment and processing of adverse event reports associated with your products Aggregate Report Management Authoring of cumulative safety reports such as PADERs and PSURs Management of reporting schedules and process timelines to allow for business partner involvement and electronic publishing as needed Safety Data Exchange Agreement (SDEA) Management Authoring and/or reviewing safety agreements with business partners Correspondence and reconciliation with partners Regulatory Reporting Management of Individual Case Safety Report (ICSR) submissions to regulatory authorities

Top 5 Recent Tweets

March 17, 2018AccelovanceHappy St. Patrick's Day from your friends at Accelovance! »
March 14, 2018AccelovanceMachine learning and AI are the hot topics of today, and not surprisingly, they're being applied to health care and…
March 12, 2018BioBuzzMarylandCongrats to @Accelovance on being Nominated As Best CRO for 2018 Vaccine Industry Excellence (ViE) Awards for 11Th…

Top 5 Recent News Headlines

05/31/2017 Accelovance Continues Growth With Key US Sales Hires

04/10/2017 Accelovance Launches Global Initiative To Advance Promising Oncology Therapies

03/29/2017 Accelovance Positioned for Continued Growth with New Sales and Marketing Executives

01/17/2017 Panacea Pharmaceuticals and Accelovance Initiate Ph.1 Prostate Cancer Vaccine Study

10/12/2016 Accelovance Investment Further Enhances Early Phase Oncology Services | homepage =

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Accelovance, Inc. continues European expansion with acquisition of THERAMetrics AG's CRO services. [2]



Verification history